• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORK LIMITED SPACEOAR SYSTEM; ABSORBABLE PERIRECTAL SPACER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORK LIMITED SPACEOAR SYSTEM; ABSORBABLE PERIRECTAL SPACER Back to Search Results
Model Number SO-2101
Device Problem Positioning Problem (3009)
Patient Problems Pain (1994); Discomfort (2330)
Event Date 11/11/2020
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number.Therefore, the expiration and device manufacture dates are unknown.(b)(4).The complainant indicated that the device remains implanted and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation that spaceoar was implanted during a spaceoar placement procedure performed on (b)(6) 2020.Reportedly, fiducials were administered transperineal prior to spaceoar implantation and the procedure was done with no anesthesia.Additionally, saline was injected in the rectal wall during hydrodissection.According to the complainant, the patient experienced discomfort and pain days after the procedure prior to radiation therapy.Magnetic resonance imaging (mri) for radiation treatment was performed and it showed that the gel infiltrated the rectal wall.Reportedly, 10cc of the hydrogel was noted to be in the rectal wall.The physician concluded that the discomfort and pain were due to the spaceoar being present in the rectum.The patient described pain in rectum, exactly where spaceoar was placed.The patient was treated with percocet.Reportedly, the patient pain was slowly improving.The patient will receive external beam radiation therapy (ebrt) 60/20 fractions.
 
Event Description
It was reported to boston scientific corporation that spaceoar was implanted during a spaceoar placement procedure performed on (b)(6) 2020.Reportedly, fiducials were administered transperineally prior to spaceoar implantation and the procedure was done with no anesthesia.Additionally, saline was injected in the rectal wall during hydrodistention.According to the complainant, the patient experienced discomfort and pain days after the procedure prior to radiation therapy.Magnetic resonance imaging (mri) for radiation treatment was performed and it showed that the gel infiltrated the rectal wall.Reportedly, 10cc of the hydrogel was noted to be in the rectal wall.The physician concluded that the discomfort and pain were due to the spaceoar.The patient described pain in rectum, exactly where spaceoar was placed.The patient was treated with percocet.Reportedly, the patient pain was slowly improving.The patient will receive external beam radiation therapy (ebrt) 60/20 fractions.
 
Manufacturer Narrative
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the expiration and device manufacture dates are unknown.Block h6: device code 3009 captures the reportable event of gel misplaced, non-vascular.Patient code 1994 captures the reportable event of pain.Block h10: the complainant indicated that the device remains implanted and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental mdr will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPACEOAR SYSTEM
Type of Device
ABSORBABLE PERIRECTAL SPACER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORK LIMITED
300 boston scientific way
marlborough MA 01752
MDR Report Key11036606
MDR Text Key222306585
Report Number3005099803-2020-06018
Device Sequence Number1
Product Code OVB
UDI-Device Identifier00864661000102
UDI-Public00864661000102
Combination Product (y/n)N
PMA/PMN Number
K181465
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSO-2101
Device Catalogue NumberSO-2101
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/25/2020
Initial Date FDA Received12/18/2020
Supplement Dates Manufacturer Received11/25/2020
Supplement Dates FDA Received12/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-